WeVote
Log In

Bill

Bill

HB 3666

IDPH-PUBERTY BLOCKER REPORT

104th Regular Session Introduced by Tom Weber

Reqs all providers to quarterly report every puberty blocker prescription for minors to IDPH; keeps data anonymous, FOIA-exempt, for stats only.

Referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 3666

HB 3666 — IDPH — Puberty Blocker Reporting (Rep. Tom Weber)

Summary / Purpose

HB 3666 requires health care professionals in Illinois to report each time they prescribe a "puberty blocker" to a patient under age 18 to the Illinois Department of Public Health (IDPH). The statute establishes a quarterly reporting cadence, directs IDPH to create standardized anonymous reporting forms, and makes the collected reports confidential and exempt from disclosure under the Freedom of Information Act (FOIA). The bill adds a new section to the Department of Public Health Powers and Duties Law and amends the statutory FOIA exemptions.

Key provisions

  • Reporting duty: A health care professional must report to IDPH every instance of prescribing a puberty blocker to a person under 18.
  • Timing: Reports must be transmitted to IDPH on a quarterly basis.
  • Forms: IDPH must create and provide the forms to be used for reporting.
  • Anonymity: The required forms shall not request or require identifying information for the patient or the health care provider; IDPH must ensure anonymity of all patients and providers.
  • Confidentiality and FOIA: All reports are declared confidential, exempt from inspection and copying under FOIA, and access is limited to authorized IDPH staff for statistical purposes only.
  • Statutory changes: Adds 20 ILCS 2310/2310‑733 (new) to the Department of Public Health law and amends 5 ILCS 140/7.5 (FOIA exemptions) to reflect the exemption.

Who is affected

  • Health care professionals who prescribe puberty blockers to minors — they must submit periodic (quarterly) reports.
  • IDPH — responsible for creating forms, receiving reports, maintaining anonymity, and using data for statistical purposes.
  • Minors receiving puberty blockers — data about prescriptions will be collected in anonymized form.

Data use, privacy, and access

  • The bill requires non‑identifying reporting and limits departmental access to authorized staff only for statistical analysis.
  • Reports are exempt from FOIA and designated confidential under state law.

Legislative status & timeline (selected)

  • Filed by Rep. Tom Weber: 02/07/2025
  • First Reading / Referred to Rules Committee: 02/18/2025
  • Passed the House / Received by Senate: 04/29/2025
  • Senate actions: Read first time and referred to Business & Commerce: 05/16/2025 (Record contains committee hearings, substitute, and engrossment activity in April 2025.)

Potential considerations

  • Administrative burden on providers for frequent reporting and on IDPH to process and analyze submissions.
  • Supporters may cite public‑health monitoring and statistical tracking; critics may raise concerns about confidentiality safeguards, enforcement, and potential chilling effects despite anonymity provisions.
  • Practical implementation will depend on IDPH form design, data security practices, and definitions used for "puberty blocker."

If you want, I can produce a one‑page fact sheet or a short timeline of next procedural steps in the legislature.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.